Remote Follow-Up After Atrial Fibrillation Ablation

Remote Follow-Up After Atrial Fibrillation Ablation - HYBRID-AF

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

DRKS

Registry ID

DRKS00040250

Enrollment

200

Registered

2026-05-06

Start date

2026-05-14

Completion date

Unknown

Last updated

2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

I48.9

Interventions

Group 1: Inpatient ablation / app-based digital follow-up / non-randomised control group Patients undergoing atrial fibrillation ablation in the conventional inpatient setting receive structured digit

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Recent atrial fibrillation ablation Access to a smartphone and ability to perform daily measurements or app-based study procedures Written informed consent and willingness to participate and comply with study instructions

Exclusion criteria

Exclusion criteria: Life expectancy < 3 months due to non-cardiac disease Cognitive, physical, or language limitations preventing completion of study procedures or valid informed consent Concurrent participation in another interventional study that could confound the study outcomes Investigator assessment that participation cannot be conducted safely

Design outcomes

Primary

Measure	Time frame
The primary endpoint is the feasibility and adherence to a 12-week digital follow-up program after atrial fibrillation ablation, assessed as the proportion of participants with at least 5 measurement days per week during the follow-up period.	—

Secondary

Measure	Time frame
Overall adherence: Proportion of completed measurements relative to the scheduled measurements. Temporal usage patterns: Comparison of measurement frequency on weekends and public holidays versus working days. Patient satisfaction and usability: Assessed using the System Usability Scale (SUS) and global satisfaction ratings. Change in AF-specific quality of life: Measured over 12 weeks using the AFEQT overall score. Unplanned medical contacts: Number of unplanned in-person or telemedicine physician contacts within 12 weeks. Healthcare utilization: Number of emergency contacts and rehospitalizations within 12 weeks. Descriptive health-economic parameters: Assessment of health-economic metrics in the context of the Hybrid-DRG model.	—

Measure

Time frame

Overall adherence: Proportion of completed measurements relative to the scheduled measurements. Temporal usage patterns: Comparison of measurement frequency on weekends and public holidays versus working days. Patient satisfaction and usability: Assessed using the System Usability Scale (SUS) and global satisfaction ratings. Change in AF-specific quality of life: Measured over 12 weeks using the AFEQT overall score. Unplanned medical contacts: Number of unplanned in-person or telemedicine physician contacts within 12 weeks. Healthcare utilization: Number of emergency contacts and rehospitalizations within 12 weeks. Descriptive health-economic parameters: Assessment of health-economic metrics in the context of the Hybrid-DRG model.

—

Countries

Germany

Contacts

Public ContactFelix Hohendanner

Deutsches Herzzentrum der Charité

Felix.Hohendanner@dhzc-charite.de+493045050

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Jun 11, 2026